PARP1 and neoplasm: However, heterozygous BRCA1 Cys61Gly mutant mice with tissue-specific loss of p53 develop mammary carcinomas resembling BRCA1 null tumours, although these tumours rapidly developed resistance to cisplatin and PARP inhibitors [170].